Thoma Bravo Fund X, L.P.'s Form 4 filing
Dynatrace, Inc. (DT) · filed Feb 14, 2024
- Accession no.
- 0000950170-24-015202
- Filed
- Feb 14, 2024, 4:05 PM ET
- Trade date
- Feb 12-14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $749.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thoma Bravo Fund X, L.P.CIK 0001537211 | 10% Owner |
| Thoma Bravo Fund X-A, L.P.CIK 0001537212 | 10% Owner |
| Thoma Bravo Special Opportunities Fund I, L.P.CIK 0001579904 | 10% Owner |
| Thoma Bravo Fund XI, L.P.CIK 0001606286 | 10% Owner |
| Thoma Bravo Fund XI-A, L.P.CIK 0001606287 | 10% Owner |
| Thoma Bravo Executive Fund XI, L.P.CIK 0001606288 | 10% Owner |
| Thoma Bravo Partners XI, L.P.CIK 0001722232 | 10% Owner |
| Thoma Bravo Partners X, L.P.CIK 0001783009 | 10% Owner |
| Thoma Bravo Special Opportunities Fund I Aiv, L.P.CIK 0001783011 | 10% Owner |
| Thoma Bravo Ugp, LLCCIK 0001813487 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | SSaleDisposed | −14,242,929 | $52.60 | −$749,178,065.4 | 16,114,344 | Indirect | |
| Feb 14, 2024 | Common Stock | JOtherDisposed | −2,847,726 | –F4 | – | 16,114,344 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents a distribution of (i) 175,612 shares held directly by TB SOF AIV, 24,437 shares held directly by TB SOF, 351,970 shares held directly by TB Fund X and 58,947 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 27,878 shares held directly by TB Exec Fund, 1,607,653 shares held directly by TB Fund XI, and 601,229 shares held directly by TB Fund XI-A, in each case to TB Partners XI.
Referenced by the price of 1 transaction in Table I.